Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Secreted Protein Degrades LDL Receptors and Elevates Serum Cholesterol Levels

By LabMedica International staff writers
Posted on 28 Apr 2009
A secreted protein called PCSK9 (proprotein convertase subtilisin/kexin type 9) modulates LDL (low density lipoprotein) metabolism by binding to and degrading cellular LDL receptors (LDLR).

Previous studies had shown that that individuals with mutations in the PCSK9 gene, which prevented them from making normal levels of the PCSK9 protein, had LDL cholesterol levels 28% lower than those without the mutation and were protected from developing coronary heart disease. More...
On the other hand, a mutation that increased PCSK9 binding to LDLR was found to cause hypercholesterolemia due to excessive degradation of the receptor that resulted in extremely high cholesterol levels.

In the current study investigators at the University of Texas Southwestern Medical Center (Dallas, USA) sought to determine how PCSK9 functions on the molecular level.

They reported in the April 17, 2009, online edition of the Journal of Biological Chemistry (JBC) that peptide fragments of PCSK9 were able to prevent the whole protein from binding to LDLR in cell cultures. This evidence suggested that PCSK9 functioned as an extracellular factor and was not an intrinsic cellular protein.

"The fact that it works mostly extracellularly provides more opportunities to develop different kinds of therapies," said contributing author Dr. Jay Horton, professor of internal medicine and molecular genetics at the University of Texas Southwestern Medical Center. "It is much easier to design inhibitors of PCSK9 function to work outside a cell than to develop a small molecule that works inside a cell. Therefore, approaches to block the protein's activity in the blood should be successful in reducing plasma cholesterol levels. Our work paves the way for a more active pursuit of antibody and peptide approaches to block the destructive actions of PCSK9."

Related Links:

University of Texas Southwestern Medical Center




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.